These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35616105)

  • 1. Understanding the role of dopamine in cancer: past, present and future.
    Grant CE; Flis AL; Ryan BM
    Carcinogenesis; 2022 Jun; 43(6):517-527. PubMed ID: 35616105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine Alters Lipopolysaccharide-Induced Nitric Oxide Production in Microglial Cells via Activation of D1-Like Receptors.
    Wang B; Chen T; Li G; Jia Y; Wang J; Xue L; Chen Y
    Neurochem Res; 2019 Apr; 44(4):947-958. PubMed ID: 30659504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine, T cells and multiple sclerosis (MS).
    Levite M; Marino F; Cosentino M
    J Neural Transm (Vienna); 2017 May; 124(5):525-542. PubMed ID: 28283756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues.
    Bäckman L; Lindenberger U; Li SC; Nyberg L
    Neurosci Biobehav Rev; 2010 Apr; 34(5):670-7. PubMed ID: 20026186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine and dopamine receptors as target sites for cardiovascular drug action.
    Berkowitz BA
    Fed Proc; 1983 Oct; 42(13):3019-21. PubMed ID: 6137421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome-Wide Profiling of Cellular Targets Modified by Dopamine Metabolites Using a Bio-Orthogonally Functionalized Catecholamine.
    Hurben AK; Erber LN; Tretyakova NY; Doran TM
    ACS Chem Biol; 2021 Nov; 16(11):2581-2594. PubMed ID: 34726906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine, a co-regulatory component, bridges the central nervous system and the immune system.
    Li M; Zhou L; Sun X; Yang Y; Zhang C; Wang T; Fu F
    Biomed Pharmacother; 2022 Jan; 145():112458. PubMed ID: 34847478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic Regulation of Innate Immunity: a Review.
    Pinoli M; Marino F; Cosentino M
    J Neuroimmune Pharmacol; 2017 Dec; 12(4):602-623. PubMed ID: 28578466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel insights about the ascidian dopamine system: Pharmacology and phylogenetics of catecholaminergic receptors on the Phallusia nigra immune cells.
    Souza JF; Mello AA; Portal TM; Nunes-da-Fonseca R; Monteiro de Barros C
    Fish Shellfish Immunol; 2021 Feb; 109():41-50. PubMed ID: 33285170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
    Marchetti B; Giachino C; Tirolo C; Serapide MF
    Aging Cell; 2022 Apr; 21(4):e13575. PubMed ID: 35262262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mode-Selective Raman Imaging of Dopamine-Human Dopamine Transporter Interaction in Live Cells.
    Silwal AP; Lu HP
    ACS Chem Neurosci; 2018 Dec; 9(12):3117-3127. PubMed ID: 30024721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine and addiction: what have we learned from 40 years of research.
    Solinas M; Belujon P; Fernagut PO; Jaber M; Thiriet N
    J Neural Transm (Vienna); 2019 Apr; 126(4):481-516. PubMed ID: 30569209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
    Moreno-Smith M; Lee SJ; Lu C; Nagaraja AS; He G; Rupaimoole R; Han HD; Jennings NB; Roh JW; Nishimura M; Kang Y; Allen JK; Armaiz GN; Matsuo K; Shahzad MM; Bottsford-Miller J; Langley RR; Cole SW; Lutgendorf SK; Siddik ZH; Sood AK
    Neoplasia; 2013 May; 15(5):502-10. PubMed ID: 23633922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depleted dopamine in gastric cancer tissues: dopamine treatment retards growth of gastric cancer by inhibiting angiogenesis.
    Chakroborty D; Sarkar C; Mitra RB; Banerjee S; Dasgupta PS; Basu S
    Clin Cancer Res; 2004 Jul; 10(13):4349-56. PubMed ID: 15240521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas.
    Bucolo C; Leggio GM; Drago F; Salomone S
    Pharmacol Ther; 2019 Nov; 203():107392. PubMed ID: 31299315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of dopaminergic neurotransmitter phenotype in rat embryonic cerebrocortex by the synergistic action of neurotrophins and dopamine.
    Zhou J; Bradford HF; Stern GM
    Eur J Neurosci; 1996 Nov; 8(11):2328-39. PubMed ID: 8950097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors.
    Aslanoglou D; Bertera S; Sánchez-Soto M; Benjamin Free R; Lee J; Zong W; Xue X; Shrestha S; Brissova M; Logan RW; Wollheim CB; Trucco M; Yechoor VK; Sibley DR; Bottino R; Freyberg Z
    Transl Psychiatry; 2021 Feb; 11(1):59. PubMed ID: 33589583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated view on the role of dopamine in myopia.
    Feldkaemper M; Schaeffel F
    Exp Eye Res; 2013 Sep; 114():106-19. PubMed ID: 23434455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders.
    Fernández-Ruiz J; Hernández M; Ramos JA
    CNS Neurosci Ther; 2010 Jun; 16(3):e72-91. PubMed ID: 20406253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine in manic depressive illness. A pharmacological synthesis.
    Silverstone T
    J Affect Disord; 1985; 8(3):225-31. PubMed ID: 2862169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.